Shehnaaz Suliman

Insider profile

Currently holds positions in Ultragenyx Pharmaceutical Inc and Alector Inc

Performance

Overall performance
1.7

Performance over holding periods
1.7
30 days 90 days 120 days
Average return -7% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Independent Director Ultragenyx Pharmaceutical Inc Jan. 30, 2019 -
President, Chief Operating Officer Alector Inc Dec. 11, 2019 -
Senior Vice President - Corporate Development and Strategy Theravance Biopharma Inc July 31, 2017 - Dec. 31, 2019

Shehnaaz Suliman's trades of Terex Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
482.58
Quantity 44,288
Value US$1,506,069
Transaction date
Planned sale
Price
86.41
Quantity 47,379 -30.0%
Value US$1,128,789
Transaction date
Planned sale
Price
189.41
Quantity 74,233 -8.8%
Value US$440,920
Transaction date
Proposed sale
Price
65.12
Quantity 2,207
Value US$143,720
Transaction date
Planned sale
Price
33.27
Quantity 364 -1.1%
Value US$12,112
Transaction date
Planned sale
Price
32.59
Quantity 5,359 -14.3%
Value US$174,644
Transaction date
Proposed sale
Price
32.22
Quantity 5,723
Value US$184,395
Transaction date
Planned sale
Price
21.73
Quantity 10,898 -9.6%
Value US$236,802
Transaction date
Planned sale
Price
21.16
Quantity 64,102 -36.1%
Value US$1,356,347
Transaction date
Planned sale
Price
22.33
Quantity 8,874 -8.0%
Value US$198,192
Transaction date
Planned sale
Price
21.69
Quantity 66,126 -37.2%
Value US$1,433,975
Transaction date
Planned sale
Price
23.40
Quantity 2,643 -2.5%
Value US$61,858
Transaction date
Planned sale
Price
22.80
Quantity 72,357 -40.7%
Value US$1,649,986
Transaction date
Planned sale
Price
23.01
Quantity 38,489 -27.3%
Value US$885,690
Transaction date
Planned sale
Price
22.56
Quantity 36,511 -20.6%
Value US$823,626
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-22 2026-09-22 PrS Proposed sale
44,288
482.58
US$1,506,069
44,288 482.58 US$1,506,069
2026-08-26 2026-08-24 PlS Planned sale
47,379 -30.0%
86.41
US$1,128,789
47,379 -30.0% 86.41 US$1,128,789
2026-08-26 2026-08-24 PlS Planned sale
74,233 -8.8%
189.41
US$440,920
74,233 -8.8% 189.41 US$440,920
2026-08-24 2026-08-24 PrS Proposed sale
2,207
65.12
US$143,720
2,207 65.12 US$143,720
2026-06-18 2026-06-16 PlS Planned sale
364 -1.1%
33.27
US$12,112
364 -1.1% 33.27 US$12,112
2026-06-18 2026-06-16 PlS Planned sale
5,359 -14.3%
32.59
US$174,644
5,359 -14.3% 32.59 US$174,644
2026-06-16 2026-06-16 PrS Proposed sale
5,723
32.22
US$184,395
5,723 32.22 US$184,395
2026-05-18 2026-05-18 S Sale
5,740 -17.0%
25.12
US$144,189
5,740 -17.0% 25.12 US$144,189
2026-05-18 2026-05-18 PrS Proposed sale
5,740
25.12
US$144,189
5,740 25.12 US$144,189
2021-12-14 2021-12-13 PlS Planned sale
10,898 -9.6%
21.73
US$236,802
10,898 -9.6% 21.73 US$236,802
2021-12-14 2021-12-13 PlS Planned sale
64,102 -36.1%
21.16
US$1,356,347
64,102 -36.1% 21.16 US$1,356,347
2021-12-14 2021-12-10 PlS Planned sale
8,874 -8.0%
22.33
US$198,192
8,874 -8.0% 22.33 US$198,192
2021-12-14 2021-12-10 PlS Planned sale
66,126 -37.2%
21.69
US$1,433,975
66,126 -37.2% 21.69 US$1,433,975
2021-12-10 2021-12-09 PlS Planned sale
2,643 -2.5%
23.40
US$61,858
2,643 -2.5% 23.40 US$61,858
2021-12-10 2021-12-09 PlS Planned sale
72,357 -40.7%
22.80
US$1,649,986
72,357 -40.7% 22.80 US$1,649,986
2021-12-10 2021-12-08 PlS Planned sale
38,489 -27.3%
23.01
US$885,690
38,489 -27.3% 23.01 US$885,690
2021-12-10 2021-12-08 PlS Planned sale
36,511 -20.6%
22.56
US$823,626
36,511 -20.6% 22.56 US$823,626